{"title":"Comparison of Daiwa Brain Health (Hokkaido Scallop Oil Plasmalogen) and Prevagen (Apoaequorin) on Cognitive Function: An In-Office Pilot Study.","authors":"Fred Pescatore","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Daiwa Brain Health, which contains Hokkaido scallop oil plasmalogen, was compared with Prevagen, the market leader in the category of cognitive function improvement.</p><p><strong>Methods: </strong>Thirty people with subjective cognitive decline or its premorbidities were divided into 2 groups of 15 people each, and each group was given either Daiwa Brain Health or Prevagen for 90 days. The Abbreviated Mental Test Score (AMTS) and Standardized Mini-Mental State Examination (SMMSE) were conducted before treatment and after 90 days of treatment to evaluate cognitive function.</p><p><strong>Results: </strong>Participants who took Daiwa Brain Health showed statistically significant improvement in AMTS and SMMSE scores between baseline and 90 days of treatment, while participants who took Prevagen showed no statistically significant improvement in AMTS or SMMSE scores between baseline and after 90 days of treatment. The AMTS and SMMSE scores indicated higher cognitive function at 90 days after treatment for the participants who took Daiwa Brain Health compared with those who took Prevagen, and those differences were statistically significant.</p><p><strong>Conclusion: </strong>Daiwa Brain Health is more effective than Prevagen at improving cognitive function.</p>","PeriodicalId":7571,"journal":{"name":"Alternative therapies in health and medicine","volume":" ","pages":"18-20"},"PeriodicalIF":1.9000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alternative therapies in health and medicine","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Daiwa Brain Health, which contains Hokkaido scallop oil plasmalogen, was compared with Prevagen, the market leader in the category of cognitive function improvement.
Methods: Thirty people with subjective cognitive decline or its premorbidities were divided into 2 groups of 15 people each, and each group was given either Daiwa Brain Health or Prevagen for 90 days. The Abbreviated Mental Test Score (AMTS) and Standardized Mini-Mental State Examination (SMMSE) were conducted before treatment and after 90 days of treatment to evaluate cognitive function.
Results: Participants who took Daiwa Brain Health showed statistically significant improvement in AMTS and SMMSE scores between baseline and 90 days of treatment, while participants who took Prevagen showed no statistically significant improvement in AMTS or SMMSE scores between baseline and after 90 days of treatment. The AMTS and SMMSE scores indicated higher cognitive function at 90 days after treatment for the participants who took Daiwa Brain Health compared with those who took Prevagen, and those differences were statistically significant.
Conclusion: Daiwa Brain Health is more effective than Prevagen at improving cognitive function.
期刊介绍：
Launched in 1995, Alternative Therapies in Health and Medicine has a mission to promote the art and science of integrative medicine and a responsibility to improve public health. We strive to maintain the highest standards of ethical medical journalism independent of special interests that is timely, accurate, and a pleasure to read. We publish original, peer-reviewed scientific articles that provide health care providers with continuing education to promote health, prevent illness, and treat disease. Alternative Therapies in Health and Medicine was the first journal in this field to be indexed in the National Library of Medicine. In 2006, 2007, and 2008, ATHM had the highest impact factor ranking of any independently published peer-reviewed CAM journal in the United States—meaning that its research articles were cited more frequently than any other journal’s in the field.
Alternative Therapies in Health and Medicine does not endorse any particular system or method but promotes the evaluation and appropriate use of all effective therapeutic approaches. Each issue contains a variety of disciplined inquiry methods, from case reports to original scientific research to systematic reviews. The editors encourage the integration of evidence-based emerging therapies with conventional medical practices by licensed health care providers in a way that promotes a comprehensive approach to health care that is focused on wellness, prevention, and healing. Alternative Therapies in Health and Medicine hopes to inform all licensed health care practitioners about developments in fields other than their own and to foster an ongoing debate about the scientific, clinical, historical, legal, political, and cultural issues that affect all of health care.
分享
京公网安备 11010802042870号
京ICP备2023020795号-1
求助内容：
应助结果提醒方式：
扫码关注我们
